Photodynamic therapy using mono-L-aspartyl chlorin ε6 (Npe6) for the treatment of cutaneous disease: A phase I clinical study

Clinical Cancer Research

Volumn 4, Issue 11, 1998, Pages 2741-2746

  Taber, Scott W ^a,b   Fingar, Victor H ^a   Coots, Carolyn T ^a   Wieman, T Jeffery ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOTOSENSITIZING AGENT; TALAPORFIN;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; BREAST ADENOCARCINOMA; CANCER GROWTH; CANCER REGRESSION; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY DISORDER; PRIORITY JOURNAL; SKIN TUMOR; SQUAMOUS CELL CARCINOMA;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; DERMATITIS, PHOTOTOXIC; EDEMA; ERYTHEMA; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PAIN; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; TREATMENT OUTCOME;

EID: 0031785255     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Dougherty, T. J., Kaufman, J. E., Goldfarb, A., Weishaupt, K. R., Boyle, D., and Mittleman, A. Photoradiation therapy for the treatment of malignant tumors. Cancer Res., 38: 2628-2635, 1978.
2. Tokuda, Y. Primary skin cancer. In: Y. Hayata and T. J. Dougherty (eds.), Lasers and Hematoporphyrin Derivative in Cancer, pp. 88. Tokyo: Igaku-Shoin, 1983.
3. Dougherty, T. J., Lawrence, G., Kaufman, J. H., Boyle, D., Weishaupt, K. R., and Goldfarb, A. Photoradiation in the treatment of recurrent breast carcinoma. J. Natl. Cancer Inst., 62: 231-237, 1979.
4. Biel, M. A. Photodynamic therapy and the treatment of neoplastic diseases of the larynx. Laryngoscope, 104: 399-403, 1994.
5. Schweitzer, V. G. Photodynamic therapy for treatment of head and neck cancer. Otolaryngol. Head Neck Surg., 102: 225-232, 1990.
6. Heier, S. K., Rothman, K., Heier, L. M., and Rosenthal, W. S. Phototherapy of esophageal malignancies. Laser Surg. Med. Suppl., 5: 51, 1993.
7. Edell, E. S., and Cortese, D. A. Bronchoscopic localization and treatment of occult lung cancer. Chest, 96: 919-921, 1989.
8. Hayata, Y., Kato, H., Konaka, C., Ohunaka, T., and Furukawa, K. Overview of clinical PDT. In: P. Spinelli, M. Dal Fante, and R. Marchesini (eds.), Photodynamic Therapy and Biomedical Lasers, pp. 614-617. Amsterdam: Elsevier Science Publishers B. V., 1992.
9. Kato, H., Horia, T., Faruse, K., Fukuoka, M., Suzuki, S., Hiki, Y., Ito, Y., Mimura, S., Tenjin, Y., and Hisazumi, H. Photodynamic therapy for cancers: a clinical trial of porfimer sodium in Japan. Jpn. J. Cancer Res., 84: 1209-1214, 1993.
10. Henderson, B. W., and Dougherty, T. J. How does photodynamic therapy work? Photochem. Photobiol., 55: 145-157, 1992.
11. Weishaupt, W. R., Gomer, C. J., and Dougherty, T. J. Identification of sinslet oxygen as the cytotoxic agent in inactivation of a murine tumor. Cancer Res., 36: 2326-2329, 1976.
12. Dougherty, T. J. Photodynamic therapy. Photochem. Photobiol., 58: 895-900, 1993.
13. Edell, E. S., and Cortese, D. A. Photodynamic therapy in the management of early superficial squamous cell carcinoma as an alternative to surgical resection. Chest, 102: 1319-1322, 1992.
14. Nelson, J. S., Roberts, W. G., and Berns, M. W. In vivo studies on the utilization of mono-L-aspartyl chlorin (Npe6) for photodynamic therapy. Cancer Res., 47: 4681-4685, 1987.
15. Gomer, C. J., and Ferrario, A. Tissue distribution and photosensitizing properties of mono-L-aspartyl chlorin e6 in a mouse tumor model. Cancer Res., 50: 3985-3990, 1990.
16. Volz, W., and Allen, R. Cutaneous phototoxicity of NPe6 in man. In: P. Spinelli, M. Dal Fante, and R. Marchesini (eds.), Photodynamic Therapy and Biomedical Lasers, pp. 614-617. Amsterdam: Elsevier Science Publishers B. V., 1992.
17. Moan, J. Properties for optimal PDT sensitizers. J. Photochem. Photobiol., 5: 521-524, 1990.
18. Roberts, W. G., Smith, K. M., McCullough, J. L., and Berns, M. W. Skin photosensitivity and photodestruction of several potential photodynamic sensitizers. Photochem. Photobiol., 49: 431-438, 1989.
19. Ferrario, A., Kessel, D., and Gomer, C. J. Metabolic properties and photosensitizing responsiveness of mono-L-aspartyl chlorin e6 in a mouse tumor model. Cancer Res., 52: 2890-2893, 1992.
20. Nelson, J. S., Liaw, L. H., Orenstein, A., Roberts, W. G., and Berns, M. Mechanism of tumor destruction following photodynamic therapy with hematoporphyrin derivative, chlorin, and phthalocyanine. J. Natl. Cancer Inst., 80: 1599-1605, 1988.
21. McMahon, K. S., Wieman, T. J., Moore, P. H., and Fingar, V. H. Effects of photodynamic therapy using mono-L-aspartyl chlorin e6 on vessel constriction, vessel leakage and tumor response. Cancer Res., 54: 5370-5374, 1994.
22. Fingar, V. H., and Henderson, B. W. Drug and light dose dependence of photodynamic therapy: a study of tumor and normal tissue response. Photochem. Photobiol., 46: 837-841, 1987.
23. Star, W. M., Marijnissen, H. P. A., van den Berg-Blok, S., Versteeg, J. A. C., Franken, K. A. P., and Reinshold, H. S. Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers. Cancer Res., 46: 2532-2540, 1986.
24. Dougherty, T. J., Cooper, M. T., and Mang, T. S. Cutaneous phototoxic occurrences in patients receiving photofrin. Laser Surg. Med., 10: 485-488, 1990.
25. Mullooly, V. M., Abramson, A. L., and Shikowitz, M. J. Dihematoporphyrin ether-induced photosensitivity in laryngeal papilloma patients. Lasers Surg. Med., 10: 349-356, 1990.